Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Observe the therapeutic efficacy of human menopausal gonadotropin combining with human chorionic gonadotropin in adolescent boys with congenital hypogonadotropic hypogonadism.
Observe safety and efficacy of human menopausal gonadotropin and human chorionic gonadotropin treating congenital hypogonadotropic hypogonadism in teenagers; which as clinic recommendation, may provide clinical basis for establishing standard treatment guideline in the future. Establish technological process and follow-up precept for human menopausal gonadotropin and human chorionic gonadotropin injection treating congenital hypogonadotropic hypogonadism in teenagers. And find safety and effective dose for teenagers.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Human Menopausal Gonadotropin | Experimental | Human menopausal gonadotropin contains follicle-stimulating hormone (FSH) and luteinizing hormone (LH) |
|
| Human Chorionic Gonadotropin | Experimental | Human chorionic gonadotropin (hCG) is a hormone produced by the embryo after implantation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Human Menopausal Gonadotropin | Drug | Human Menopausal Gonadotropin injection treating congenital hypogonadotropic hypogonadism in teenagers |
|
| Measure | Description | Time Frame |
|---|---|---|
| testicular volume | Change from Baseline testicular volume at 3 months after treatment |
| Measure | Description | Time Frame |
|---|---|---|
| The levels of testosterone serum (It were measured with chemiluminescent immunoassay Elecsys) | Testosterone changes from 3 months onwards after treatment compared to pretreatment |
Not provided
Inclusion Criteria
Criteria A
Criteria B
Criteria C
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ying Liu, master | Contact | +8615001091953 | judyjudy5479@aliyun.com | |
| Chunxiu Gong, doctor | Contact | +8613370115001 | chunxiugong@sina.com |
| Name | Affiliation | Role |
|---|---|---|
| Chunxiu Gong, doctor | Beijing Children's Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beijing Children's Hospital | Recruiting | Beijing | Beijing Municipality | 100045 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33813517 | Derived | Liu Y, Ren XY, Peng YG, Chen SK, Cheng XR, Qin M, Wang XL, Song YN, Fan LJ, Gong CX. Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism. Chin Med J (Engl). 2021 Mar 31;134(10):1152-1159. doi: 10.1097/CM9.0000000000001419. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Feb 8, 2023 | |
| Reset | Nov 14, 2023 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Human Chorionic Gonadotropin | Drug | Human Chorionic Gonadotropin injection treating congenital hypogonadotropic hypogonadism in teenagers |
|
|
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Feb 8, 2023 | Nov 14, 2023 |
| ID | Term |
|---|---|
| D017436 | Kallmann Syndrome |
| D007006 | Hypogonadism |
| ID | Term |
|---|---|
| D058490 | Disorder of Sex Development, 46,XY |
| D012734 | Disorders of Sex Development |
| D014564 | Urogenital Abnormalities |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D030342 | Genetic Diseases, Inborn |
| D006058 | Gonadal Disorders |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D008596 | Menotropins |
| D006063 | Chorionic Gonadotropin |
| ID | Term |
|---|---|
| D006065 | Gonadotropins, Pituitary |
| D006062 | Gonadotropins |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D010908 | Pituitary Hormones, Anterior |
| D010907 | Pituitary Hormones |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D001688 | Biological Products |
| D045424 | Complex Mixtures |
| D010926 | Placental Hormones |
| D011257 | Pregnancy Proteins |
| D011506 | Proteins |
Not provided
Not provided